Search by Drug Name or NDC
NDC 29998-0001-30 Fludeoxyglucose F 18 40 mCi/mL Details
Fludeoxyglucose F 18 40 mCi/mL
Fludeoxyglucose F 18 is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Kettering Medical Center. The primary component is FLUDEOXYGLUCOSE F-18.
Product Information
| NDC | 29998-0001 |
|---|---|
| Product ID | 29998-001_8d1b364e-50f4-4cc1-8153-9b05ae02220d |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fludeoxyglucose F 18 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fludeoxyglucose F-18 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mCi/mL |
| Substance Name | FLUDEOXYGLUCOSE F-18 |
| Labeler Name | Kettering Medical Center |
| Pharmaceutical Class | Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204759 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 29998-0001-30 (29998000130)
| NDC Package Code | 29998-001-30 |
|---|---|
| Billing NDC | 29998000130 |
| Package | 30 mL in 1 VIAL, MULTI-DOSE (29998-001-30) |
| Marketing Start Date | 2011-12-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |